Alemtuzumab and Pentostatin In T-cell Neoplasms
Condition(s):Lymphoma; LeukemiaLast Updated:August 7, 2012Terminated
Hide Studies Not Open or Pending
Condition(s):Lymphoma; LeukemiaLast Updated:August 7, 2012Terminated
Condition(s):Lymphoma, Large-Cell, Anaplastic; Lymphoma, NK-cell; Lymphoma, T-cellLast Updated:June 28, 2017Completed
Condition(s):T-Cell and NK-Cell NeoplasmLast Updated:January 24, 2024Recruiting
Condition(s):Mature T-Cell and NK-Cell NeoplasmLast Updated:June 10, 2022Completed
Condition(s):Unrecognized Condition: Mature B or T-cell NeoplasmLast Updated:December 29, 2017Terminated
Condition(s):T-Cell Neoplasm; Lymphoproliferative DisordersLast Updated:December 13, 2023Recruiting
Condition(s):Peripheral T Cell Lymphoma; PTCL; Extranodal NK/T-cell Lymphoma; Extranodal NK/T-cell Lymphoma, Nasal Type; Extranodal NK T Cell Lymphoma; Extranodal NK T Cell Lymphoma, Nasal; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Angioimmunoblastic T-Cell Lymphoma Recurrent; Angioimmunoblastic T-Cell Lymphoma Refractory; Peripheral T-cell Lymphoma NOS; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Peripheral T-Cell Lymphoma Refractory; Anaplastic Large Cell Lymphoma; Anaplastic Large Cell Lymphoma, ALK-Positive; Anaplastic Large Cell Lymphoma, ALK-negative; ALK-negative Anaplastic Large Cell Lymphoma; ALK-Positive Anaplastic Large Cell Lymphoma; Cutaneous T-cell LymphomaLast Updated:May 4, 2022Completed
Condition(s):Adult T Cell Leukemia/LymphomaLast Updated:May 23, 2016Completed
Condition(s):Leukemia; Lymphoma; Mature T-cell and Nk-cell Neoplasms; Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 15, 2019Completed
Condition(s):Lung CancerLast Updated:September 19, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.